Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Premature Birth 1Neoplasm Metastasis 1Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Utrogestan × Clear all
NCT05091866 2026-05-05

Natural Progesterone for the Treatment of Recurrent Glioblastoma

Emory University

Phase EARLY_PHASE1 Terminated
4 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00422526 2007-01-17

Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial

King's College Hospital NHS Trust

Phase 3 Completed
250 enrolled

Neoplasm Metastasis, Premature Birth

Data powered by HemOnc (CC BY 4.0) Colophon âš¡